v3.26.1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
(Accumulated Deficit) Retained Earnings
Accumulated Other Comprehensive Income
Noncontrolling Interest
Balance at Dec. 31, 2024 $ 1,647,855 $ 1,742 $ 1,866,850 $ (222,155) $ 1,418  
Balance, shares at Dec. 31, 2024   174,245,990        
Net income [1] 29,417     29,542   $ (125)
Other comprehensive income , net of tax (3,287)       (3,287)  
Share-based compensation 15,681   15,681      
Exercise of stock options 345   345      
Exercise of stock options, shares   36,253        
Issuance of common stock for settlement of RSUs   $ 11 (11)      
Issuance of common stock for settlement of RSUs, shares   1,052,536        
Tax effect of net share settlement of equity awards (2,767) $ (1) (2,766)      
Tax effect of net share settlement of equity awards, shares   (151,345)        
Balance at Mar. 31, 2025 1,687,244 $ 1,752 1,880,099 (192,613) (1,869) (125)
Balance, shares at Mar. 31, 2025   175,183,434        
Balance at Dec. 31, 2025 1,875,139 $ 1,921 1,954,482 (74,647) (6,691) 74
Balance, shares at Dec. 31, 2025   192,124,125        
Net income [1] 148,769     148,767   2
Other comprehensive income , net of tax 5,426       5,426  
Share-based compensation 3,676   3,676      
Exercise of stock options 12,092 $ 14 12,078      
Exercise of stock options, shares   1,377,708        
Issuance of common stock for settlement of RSUs   $ 13 (13)      
Issuance of common stock for settlement of RSUs, shares   1,316,385        
Tax effect of net share settlement of equity awards (5,708) $ (1) (5,707)      
Tax effect of net share settlement of equity awards, shares   (143,689)        
Share repurchase (60,000) $ (15)   (59,985)    
Share repurchase, shares   (1,464,807)        
Other (13)         (13)
Balance at Mar. 31, 2026 $ 1,979,381 $ 1,932 $ 1,964,516 $ 14,135 $ (1,265) $ 63
Balance, shares at Mar. 31, 2026   193,209,722        
[1]

(1) Net income (loss) to the Company for the three months ended March 31, 2026 and 2025 excludes $(159) and $(407), respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.